The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure

Status unconfirmed · Phase 3

Conditions studied: Cardiovascular Disease, Acute Renal Failure, Death

In brief

The purpose of this trial is to study the use of nesiritide in thoracic aneurysm repair to prevent acute renal failure. The study hypothesis: Nesiritide, given prophylactically prior to surgery may prevent acute renal failure requiring dialysis and/or decrease mortality.

Key facts

Study ID

NCT00110201

Run by

Ejaz, Abulate A, MD

People needed

124

Starts

2005-03-01

Expected to finish

2007-12-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• Undergoing thoracic aortic aneurysm surgery
• Impaired renal function

You may not qualify if…

• Prior history of allergy/adverse reaction to Nesiritide
• History of any organ transplant
• Preoperative intra-aortic balloon pump (IABP)
• Decompensated congestive heart failure (CHF)

Where it is running

• Shands Hospital at the University of Florida — Gainesville, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.